The Latest Breaking News from QLine Biotech

Q-Line Biotec shares to list today. Check GMP ahead of debut

Q-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a significant premium. The company's shares are expected to list at a higher price than the IPO issue price. Q-Line Biotech operates in the diagnostics and healthcare products segment.…

The Economic Times · May 29

Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%

Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong subscription on its first day. Proceeds will be used for working capital, debt repayment, and general corporate purposes.

The Economic Times · May 21